Table 1 (abstract P1006). Clinical course and co-morbidities in two age groups over 40 years
From: 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
n | Group 1* (n=61) | Group 2** (n=39) | p |
|---|---|---|---|
Sex (F:M); current age (mean±SD) (yr) | (46 :15) ;45.5 ± 2.29 | (32:7); 57.05 ± 6.81 | 0,43;<0.001 |
Mean duration since the last episode, (mean±SD, mo) | 15.3 ± 19.7 (1-60) | 35.67 ± 52.05 (1-276) | 0,012 |
Number of patients on colchicine therapy, n (%) | 59 (96.7) | 38 (97.4) | NS |
Mean colchicine dose, mg/day (current) | 1.7±0.76 | 1.41±0.45 | 0.03 |
Number of patientswith decrease in attack severity, n (%) | 54(88,5) | 35 (89,7) | NS |
Number of patients with decrease in attackfrequency, n (%) | 57(93,4) | 37 (94,8) | NS |
Co-morbidities, n (%) | |||
 Hypertension, n (%) | 12(19.6) | 13 (33.33) | NS |
 Hypotyroidism, n (%) | 12(19,6) | 4(10,2) | NS |
 Type 2 Diabetes Mellitus, n (%) | 5(8.2) | 5(12.82) | NS |
 Rheumatological diseases, n (%) | 5(8,2) | 3(7,7) | NS |
 Cardiac disease, n (%) | 3(4,9) | 2(5,1) | NS |
 Malignancies, n (%) | 2(3,2) | 2(5.13) | NS |
 Additionalmedications (number of patients, %) | 36 (61) | 29 (74.3) | NS |